We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Brain Cancer

Journal Scan / Research · March 16, 2021

Combination Use of Steroids + ICIs Worsens Outcomes in Patients With Brain Metastasis



Additional Info

The Combined Use of Steroids and Immune Checkpoint Inhibitors in Brain Metastasis Patients: A Systematic Review and Meta-Analysis
Neuro-oncology 2021 Feb 25;[EPub Ahead of Print], CAC Jessurun, AFC Hulsbergen, AE de Wit, IA Tewarie, TJ Snijders, J Verhoeff, J Phillips, DA Reardon, RA Mekary, MLD Broekman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading